VAERS reports by lot

GSK Hepatitis A lot 772YT: VAERS reports

52 VAERS reports list lot 772YT as a GSK Hepatitis A vaccine, received between 2023-03-01 and 2024-10-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
52
Reports
2%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1736%
Musculoskeletal613%
Gastrointestinal511%
Cardiac / Cardiovascular49%
General / Systemic (non-local)49%
Injection-site / Local reaction36%
Allergic / Anaphylactic24%
Respiratory24%
Dermatological (non-injection-site)24%
Psychiatric / Neuropsychiatric24%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
New York4
Illinois4
Michigan4
Missouri4
Idaho2
Texas2
Florida2
Iowa2
Maryland2
Colorado2
Massachusetts2

Reports by month received

2023-031
2023-053
2023-064
2023-076
2023-086
2023-093
2023-104
2023-114
2023-121
2024-011
2024-021
2024-034
2024-041
2024-065
2024-073
2024-081
2024-104

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.